HOFRAM6771209658
WILT ENZO
288HO00212
Mastitis Resistance
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK |
|---|---|---|---|---|
| 26 | 41 | 83% | 106 | 95% |
| Proof | Weighting | |
|---|---|---|
| Clinical Mastitis in First Lactation: | 108 | 33% |
| Clinical Mastitis in Later Lactations: | 104 | 33% |
| Somatic Cell Score (Combined): | 104 | 33% |
| Breed Average: | 100 |
| Clinical Mastitis in Daughters | ||
|---|---|---|
| First Lactation | Later Lactations | |
| No. Herds | 23 | |
| No. Daughters | 38 | |
| % Healthy Daughters | 97% | |
| Breed Average | 95% | |
Somatic Cell Score
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK |
|---|---|---|---|---|
| 168 | 310 | 97% | 104 | 81% |
Breed Average: 100
| First Lactation | Second Lactation | Third Lactation | |
|---|---|---|---|
| Weighting | 33% | 33% | 33% |
| Rating | 107 | 103 | 102 |
| Breed Average | 100 | 100 | 100 |
Metabolic Diseases
GEBV 26*APR| Expected % Healthy Daughters | |||||||
|---|---|---|---|---|---|---|---|
| Herds | Daughters | Reliability | Proof | %RK | 1st Lact. | Later Lact. | |
| Subclinical Ketosis | 239 | 269 | 92% | 97 | 35% | -1.5% | -2.2% |
| Clinical Ketosis | 55% | 98 | 42% | -0.7% | -0.7% | ||
| Displaced Abomasum | 27 | 31 | 63% | 97 | 35% | -1.3% | -1.0% |
| Metabolic Disease Resistance | 81% | 97 | 39% | ||||
Fertility Disorders
GEBV 26*APR| Expected % Healthy Daughters | |||||||
|---|---|---|---|---|---|---|---|
| Herds | Daughters | Reliability | Proof | %RK | 1st Lact. | Later Lact. | |
| Retained Placenta | 21 | 29 | 83% | 101 | 65% | +0.3% | +0.4% |
| Metritis | 8 | 10 | 83% | 100 | 72% | 0.0% | 0.0% |
| Cystic Ovaries | 18 | 33 | 82% | 93 | 10% | -2.1% | -3.8% |
Hoof Health
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK | Index Weighting | Expected % Healthy Daughters |
|---|---|---|---|---|---|---|
| 13 | 26 | 82% | 101 | 76% | ||
| Digital Dermatitis | 83% | 100 | 70% | 34% | 0.0% | |
| Interdigital Dermatitis | 77% | 97 | 41% | 9% | -1.0% | |
| Heel Horn Erosion | 79% | 105 | 92% | 14% | +2.5% | |
| Sole Ulcer | 81% | 102 | 76% | 20% | +1.8% | |
| Toe Ulcer | 78% | 100 | 40% | 10% | 0.0% | |
| White Line Lesion | 79% | 101 | 60% | 8% | +0.5% | |
| Sole Hemorrhage | 79% | 99 | 53% | 3% | -0.5% | |
| Interdigital Hyperplasia | 78% | 96 | 25% | 2% | -1.6% | |
Calf Health
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK | Expected % Healthy Daughters | |
|---|---|---|---|---|---|---|
| Respiratory Problems | 13 | 30 | 82% | 89 | 2% | -9.2 % |
| Diarrhea | 7 | 21 | 79% | 95 | 16% | -4.3 % |
| Calf Health | 80% | 91 | 5% | |||